TABLE 1.
Comparison of Schisandrin B (SchB) targets on adenovirus/SARS-CoV-2_hepatitis.
| Adenovirus_hepatitis | SARS-CoV-2_hepatitis | Target name |
|---|---|---|
| MET | MET | Tyrosine-protein kinase MET |
| MAPK1 | MAPK1 | MAP kinase ERK2 |
| ATM | ATM | Serine-protein kinase ATM |
| ERBB2 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 |
| CDK1 | CDK1 | Cyclin-dependent kinase 1 |
| AR | AR | Androgen receptor |
| CDK2 | CDK2 | Cyclin-dependent kinase 2 |
| ATR | ATR | Serine-protein kinase ATR |
| HSP90AA1 | HSP90AA1 | Heat shock protein HSP 90-alpha (by homology) |
| PRKDC | PRKDC | DNA-dependent protein kinase |
| EGFR | EGFR | Epidermal growth factor receptor erbB1 |
| JAK1 | JAK1 | Tyrosine-protein kinase JAK1 |
| — | ROCK2 | Rho-associated protein kinase 2 |
| — | GSK3B | Glycogen synthase kinase-3 beta |
| CASP7 | — | Caspase-7 |
| CCNE1 | — | Cyclin-dependent kinase 2/cyclin E |
| CCNB1 | — | Cyclin-dependent kinase 1/cyclin B |
| MKNK1 | — | MAP kinase-interacting serine/threonine-protein kinase MNK1 |
| PIK3CA | — | PI3-kinase p110-alpha subunit |
| CASP3 | — | Caspase-3 |
| KDR | — | Vascular endothelial growth factor receptor 2 |
| MAPK14 | — | MAP kinase p38 alpha |
| MAPK8 | — | c-Jun N-terminal kinase 1 |
| NOS2 | — | Nitric oxide synthase, inducible |
| NOS3 | — | Nitric-oxide synthase, endothelial |
| PARP1 | — | Poly [ADP-ribose] polymerase-1 |
| PGR | — | Progesterone receptor |
| RAF1 | — | Serine/threonine-protein kinase RAF |
| SRC | — | Tyrosine-protein kinase SRC |